Spatial Biology – Webinars and Online Events

We will explore how new MALDI workflows can be used to analyze lipids in degenerative disease and Alzheimer’s models, providing more depth to lipid analysis and contextualizing lipid distribution by enabling comparison to multiple protein markers.

This webinar will focus on using spatial biology approaches to understand the role of human γδ T cell subtypes in cancer, illustrating how to assess this subset in their tissue microenvironments at high resolution.

This webinar covers building tumor spatial atlases, integrating single-cell transcriptomics with spatial data, and tracking cell behavior to study interactions within cellular neighborhoods.

In this webinar, you’ll hear from Dr. Brian Gill about his research into neuron–glioma interactions and how they contribute to seizures and tumoral growth.

Technology Networks presents an exclusive Ask Me Anything session on spatial biology featuring Dr. Evan T. Keller, a Distinguished Professor of Urology and Pathology at the University of Michigan School of Medicine.

Join this webinar to discover how to integrate spatial biology and multiomics approaches to reveal the intricate interactions between cancer cells and their environment.

Join this webinar to learn the fundamentals of spatial multiplexing for single-cell proteomics and hear how it enables the in-depth exploration of complex tissue microenvironments through the detection and quantification of a virtually unlimited number of protein target analytes.

In this webinar, our expert speaker Dr. Joshua D. Campbell from Boston University will discuss the fundamentals and advanced techniques for quality control of scRNA-seq data.

Alzheimer’s disease (AD) is the most common form of dementia in the elderly population. While several peptide and protein biomarkers in cerebrospinal fluid (CSF) have been used for AD diagnosis, an unequivocal diagnosis in the early phases of AD is still lacking.

In this webinar, discover how combining a single-cell analysis platform with a novel glutamine synthetase-Chinese hamster ovary (GS-CHO) expression system can yield highly productive, scalable, clonal cell lines for developing biopharmaceuticals.